Maria de Lourdes Chauffaille
Overview
Explore the profile of Maria de Lourdes Chauffaille including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gava F, Catto L, Valera E, Francisco Dos Reis M, Pintao M, Chauffaille M, et al.
Hematol Transfus Cell Ther
. 2024 Sep;
46 Suppl 6():S417-S420.
PMID: 39278810
No abstract available.
2.
Chauffaille M, Takihi I, Prieto W, Russo P, Sandes A, Perazzio A, et al.
Int J Lab Hematol
. 2021 Apr;
43(4):O214-O217.
PMID: 33794065
No abstract available.
3.
Quaio C, Moreira C, Novo-Filho G, Sacramento-Bobotis P, Penna M, Perazzio S, et al.
Am J Med Genet C Semin Med Genet
. 2020 Dec;
184(4):955-964.
PMID: 33258288
Rare diseases comprise a diverse group of conditions, most of which involve genetic causes. We describe the variable spectrum of findings and clinical impacts of exome sequencing (ES) in a...
4.
Weinhauser I, Pereira-Martins D, Ortiz C, Silveira D, Simoes L, Bianco T, et al.
Cancers (Basel)
. 2020 Oct;
12(11).
PMID: 33120864
The SLIT-ROBO axis plays an important role in normal stem-cell biology, with possible repercussions on cancer stem cell emergence. Although the Promyelocytic Leukemia (PML) protein can regulate expression in the...
5.
Thome C, Ferreira G, Pereira-Martins D, Augusto Dos Santos G, Ortiz C, de Souza L, et al.
Sci Rep
. 2020 Jun;
10(1):10315.
PMID: 32587277
Non-T cell activation linker (NTAL) is a lipid raft-membrane protein expressed by normal and leukemic cells and involved in cell signaling. In acute promyelocytic leukemia (APL), NTAL depletion from lipid...
6.
de Faria-Moss M, Yamamoto M, Arrais-Rodrigues C, Criado I, Perez Gomes C, Chauffaille M, et al.
Haematologica
. 2019 Nov;
105(6):e298-e301.
PMID: 31727770
No abstract available.
7.
Lucena-Araujo A, Coelho-Silva J, Pereira-Martins D, Silveira D, Koury L, Melo R, et al.
Blood
. 2019 Jul;
134(12):951-959.
PMID: 31292112
By combining the analysis of mutations with aberrant expression of genes previously related to poorer prognosis in both acute promyelocytic leukemia (APL) and acute myeloid leukemia, we arrived at an...
8.
de Noronha T, Mitne-Neto M, Chauffaille M
Autops Case Rep
. 2019 May;
9(2):e2018084.
PMID: 31086779
mutations are rare in acute myeloid leukemia (AML), and -mutated acute myeloid leukemia (AML) patients usually have a previous history of myeloproliferative neoplasms (MPNs). Current advances in laboratory techniques, such...
9.
de Noronha T, Mitne-Neto M, Chauffaille M
Hematol Transfus Cell Ther
. 2019 May;
41(2):181-184.
PMID: 31084768
No abstract available.
10.
Lucena-Araujo A, Pereira-Martins D, Koury L, Franca-Neto P, Coelho-Silva J, de Deus Wagatsuma V, et al.
Blood Adv
. 2018 Jan;
1(21):1807-1814.
PMID: 29296827
Although overexpression of the brain and acute leukemia, cytoplasmic () gene is associated with primary resistant disease and shorter relapse-free, disease-free, and overall survival in different subsets of acute myeloid...